Our current Immuno-Oncology status Myeloma Treatment has improved markedly the last 15 years with many new available treatments.  Patients are living much longer and have good therapeutic options for induction therapy and relapsed disease.  The newest and most promising treatments have occurred in immunotherapy or IO (Immuno-Oncology).  During myeloma’s “November to Remember” in 2015 patients [...]